Farms.com Home   News

Coalition Raises Awareness About Container Crunch

A growing coalition of commodity associations has launched a campaign to raise awareness about the negative impact of the global container crunch.

Greg Northey is Vice President of Corporate Affairs with Pulse Canada.

"This is a problem we've been facing for a year and a half, a global problem, but certainly in Canada we've been feeling the effects just like pretty much every other country," he said. "What it's meaning for the grain sector and any other commodity that has to export is just the lack of service, accessibility, availability of containers and access to vessels to get our containers overseas to our trade markets. It's been getting progressively worse for the past few months."

Northey says the cost to send a container of grain has doubled over the past couple of months.

The coalition is calling for the Government of Canada to call an immediate investigation and to create a joint industry-government task force.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.